Evidence map›Paper›PMID 42553376›Full record

ArticleCureus2026

Occult Insulinoma: A 19-Year Diagnostic Delay in a Patient With Recurrent Hypoglycemia.

Poleth G Medrano-Madrid, Edgar A Espinoza-Beltrán, Jose M Espinoza-Beltrán, Erika M Espinoza-Beltrán, David A Gaspar-Duran

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Poleth G Medrano-MadridInternal Medicine, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar, Hospital General Culiacán, Culiacán, MEX.
Edgar A Espinoza-BeltránInternal Medicine, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar, Hospital General Culiacán, Culiacán, MEX.
Jose M Espinoza-BeltránRadiology, Centro de Investigación y Docencia en Ciencias de la Salud, Hospital Civil de Culiacán, Culiacán, MEX.
Erika M Espinoza-BeltránEndocrinology, Faculty of Medicine, Universidad Autónoma de Sinaloa, Culiacán, MEX.
David A Gaspar-DuranPathology, Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar, Hospital General Culiacán, Culiacán, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent hypoglycemia may present a diagnostic challenge when initial biochemical and imaging studies are inconclusive. We report the case of a 47-year-old man who presented with a 19-year history of recurrent hypoglycemic episodes characterized by diaphoresis, tremor, palpitations, intense hunger, dizziness, blurred vision, and impaired concentration. Initial evaluation documented hypoglycemia; however, insulin and C-peptide concentrations did not meet the diagnostic criteria for endogenous hyperinsulinism, and abdominal computed tomography (CT) failed to identify a pancreatic lesion. Persistent symptoms prompted reevaluation 19 years later, revealing endogenous hyperinsulinemic hypoglycemia and a 16-mm pancreatic body lesion on contrast-enhanced magnetic resonance imaging (MRI). The patient underwent distal pancreatectomy, and histopathological examination confirmed a well-differentiated pancreatic neuroendocrine tumor consistent with insulinoma. Following surgery, hypoglycemic symptoms completely resolved. This case highlights how insulinoma may remain clinically occult for prolonged periods when initial biochemical and imaging findings are nondiagnostic. Persistent or recurrent hypoglycemic symptoms should prompt continued clinical suspicion and periodic reassessment, even after inconclusive investigations, as repeat biochemical evaluation and evolving localization strategies may facilitate definitive diagnosis and treatment.

Indexed as

diagnostic delayendogenous hyperinsulinemic hypoglycemiainsulinomapancreatic neuroendocrine tumorrecurrent hypoglycemiawhipple's triad

Identifiers

PMID42553376
PMCPMC13433900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.